TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T20178	Tumor necrosis factor	B07BYC	1-(3-Carboxypropyl)-3,7-dimethylxanthine	Investigative	151419	C11H14N4O4	266.25	CN1C=NC2=C1C(=O)N(C(=O)N2C)CCCC(=O)O	IC50 > 200000 nM	Non binder
T20178	Tumor necrosis factor	B2BM3Y	Mesalamine	Investigative	4075	C7H7NO3	153.14	C1=CC(=C(C=C1N)C(=O)O)O	IC50 = 20600000 nM	Non binder
T20178	Tumor necrosis factor	B31GAP	3-Methyl-8-sulfanylidene-7,9-dihydropurine-2,6-dione	Investigative	3081830	C6H6N4O2S	198.21	CN1C2=C(C(=O)NC1=O)NC(=S)N2	IC50 > 200000 nM	Non binder
T20178	Tumor necrosis factor	B47JSF	(5S)-5-[[5-(1-Methylpyrazol-4-yl)-3-oxo-1H-isoindol-2-yl]methyl]-5-(2-pyridin-3-ylethynyl)imidazolidine-2,4-dione	Investigative	46200562	C23H18N6O3	426.4	CN1C=C(C=N1)C2=CC3=C(CN(C3=O)C[C@]4(C(=O)NC(=O)N4)C#CC5=CN=CC=C5)C=C2	IC50 = 10000001 nM	Non binder
T20178	Tumor necrosis factor	B4UCD3	4-(1-Methyl-2,4-dioxo-1,4-dihydro-2H-pteridin-3-yl)-butyric acid	Investigative	10515726	C11H12N4O4	264.24	CN1C2=NC=CN=C2C(=O)N(C1=O)CCCC(=O)O	IC50 > 200000 nM	Non binder
T20178	Tumor necrosis factor	B51DPB	3-(1,3-Dioxoisoindol-2-yl)-3-phenylpropanamide	Investigative	461665	C17H14N2O3	294.3	C1=CC=C(C=C1)C(CC(=O)N)N2C(=O)C3=CC=CC=C3C2=O	IC50 = 260000 nM	Non binder
T20178	Tumor necrosis factor	B5TR1G	4-(2,4-Dioxo-1-propyl-1,4-dihydro-2H-pteridin-3-yl)-butyric acid	Investigative	10661296	C13H16N4O4	292.29	CCCN1C2=NC=CN=C2C(=O)N(C1=O)CCCC(=O)O	IC50 > 200000 nM	Non binder
T20178	Tumor necrosis factor	B7MEC0	4-(8-Bromo-3,7-dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-purin-1-ylmethyl)-benzoic acid methyl ester	Investigative	10692755	C16H15BrN4O4	407.22	CN1C2=C(N=C1Br)N(C(=O)N(C2=O)CC3=CC=C(C=C3)C(=O)OC)C	IC50 > 200000 nM	Non binder
T20178	Tumor necrosis factor	B8HV5X	4-(3,7-Dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-purin-1-ylmethyl)-benzoic acid methyl ester	Investigative	10782487	C16H16N4O4	328.32	CN1C=NC2=C1C(=O)N(C(=O)N2C)CC3=CC=C(C=C3)C(=O)OC	IC50 > 200000 nM	Non binder
T20178	Tumor necrosis factor	BC0E3T	(5R)-5-[(5-Methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[2-[4-[4-(6-thiomorpholin-4-ylpyridin-2-yl)phenyl]phenyl]ethynyl]imidazolidine-2,4-dione	Investigative	46200106	C36H31N5O4S	629.7	COC1=CC2=C(CN(C2=O)C[C@@]3(C(=O)NC(=O)N3)C#CC4=CC=C(C=C4)C5=CC=C(C=C5)C6=NC(=CC=C6)N7CCSCC7)C=C1	IC50 = 1000001 nM	Non binder
T20178	Tumor necrosis factor	BH0J2P	4-(1-Methyl-2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl)-butyric acid	Investigative	10730172	C13H14N2O4	262.26	CN1C2=CC=CC=C2C(=O)N(C1=O)CCCC(=O)O	IC50 > 200000 nM	Non binder
T20178	Tumor necrosis factor	BHW0N5	4-(1-Methyl-2,4-dioxo-6-phenyl-1,4-dihydro-2H-pteridin-3-yl)-butyric acid ethyl ester	Investigative	10737740	C19H20N4O4	368.4	CCOC(=O)CCCN1C(=O)C2=NC(=CN=C2N(C1=O)C)C3=CC=CC=C3	IC50 > 200000 nM	Non binder
T20178	Tumor necrosis factor	BKXD81	(5R)-5-[(5-Methoxy-3-oxo-1H-isoindol-2-yl)methyl]-5-[2-[4-(6-thiomorpholin-4-ylpyridin-2-yl)phenyl]ethynyl]imidazolidine-2,4-dione	Investigative	46199949	C30H27N5O4S	553.6	COC1=CC2=C(CN(C2=O)C[C@@]3(C(=O)NC(=O)N3)C#CC4=CC=C(C=C4)C5=NC(=CC=C5)N6CCSCC6)C=C1	IC50 = 1000001 nM	Non binder
T20178	Tumor necrosis factor	BQU2W7	(5R)-5-[[5-(1-Methylpyrazol-4-yl)-3-oxo-1H-isoindol-2-yl]methyl]-5-(2-pyridin-3-ylethynyl)imidazolidine-2,4-dione	Investigative	46200564	C23H18N6O3	426.4	CN1C=C(C=N1)C2=CC3=C(CN(C3=O)C[C@@]4(C(=O)NC(=O)N4)C#CC5=CN=CC=C5)C=C2	IC50 = 10000001 nM	Non binder
T20178	Tumor necrosis factor	BTO43Q	4-(8-Mercapto-3,7-dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-purin-1-ylmethyl)-benzoic acid ethyl ester	Investigative	44382442	C17H18N4O4S	374.4	CCOC(=O)C1=CC=C(C=C1)CN2C(=O)C3=C(NC(=S)N3C)N(C2=O)C	IC50 > 200000 nM	Non binder
T20178	Tumor necrosis factor	BV47TY	4-(4-Methyl-5,7-dioxo-4,5-dihydro-7H-[1,2,5]thiadiazolo[3,4-d]pyrimidin-6-yl)-butyric acid	Investigative	10539960	C9H10N4O4S	270.27	CN1C2=NSN=C2C(=O)N(C1=O)CCCC(=O)O	IC50 > 200000 nM	Non binder
T20178	Tumor necrosis factor	BW82BR	5-[5-Methoxy-6-[2-[(4R)-4-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-2,5-dioxoimidazolidin-4-yl]ethynyl]pyridin-2-yl]pyridine-2-carbonitrile	Investigative	68042923	C27H20N6O5	508.5	COC1=CC2=C(CN(C2=O)C[C@@]3(C(=O)NC(=O)N3)C#CC4=C(C=CC(=N4)C5=CN=C(C=C5)C#N)OC)C=C1	IC50 = 10000001 nM	Non binder
T20178	Tumor necrosis factor	BXM06Z	3-[5-Methoxy-6-[2-[(4R)-4-[(5-methoxy-3-oxo-1H-isoindol-2-yl)methyl]-2,5-dioxoimidazolidin-4-yl]ethynyl]pyridin-2-yl]benzonitrile	Investigative	68042927	C28H21N5O5	507.5	COC1=CC2=C(CN(C2=O)C[C@@]3(C(=O)NC(=O)N3)C#CC4=C(C=CC(=N4)C5=CC=CC(=C5)C#N)OC)C=C1	IC50 = 1000001 nM	Non binder